YOLFTbeta
00

Zhejiang Hisoar Pharmaceutical Co Ltd

002099 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

5.61CNY-0.13 (-2.26%)

Price History

Full chart

Market Stats

Previous Close5.74
Open5.74
Day Range5.60 – 5.85
52-Week Range4.87 – 9.09
Volume11.78M
Market Cap9.96B
P/E (TTM)0.00
Forward P/E86.96
EPS-0.11
Dividend Yield0.00%
Beta0.32
50-Day Avg5.41
200-Day Avg6.21

About

Zhejiang Hisoar Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates in China and internationally. It operates through Pharmaceutical Industry, Dye Industry, and Others segments. The company offers antibiotics, cardiovascular drugs, hypoglycemic agents, formulations, and fine chemicals. It also provides dyes and pigment intermediates; environmental protection-related equipment; medical chemical supplies and appliances; and other chemical intermediates. In addition, the company engages in technology research and development; trading; hazardous waste treatment; equity investment; technical consulting and other consulting services; and venture capital activities. It exports its products to approximately 30 countries, including Europe, America, and Asia. Zhejiang Hisoar Pharmaceutical Co., Ltd. was founded in 1966 and is headquartered in Taizhou, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Guorui Xu
  • Employees2.74K
  • HeadquartersNo. 100, Waisha Branch Road, Taizhou, China, 318000, China
  • Websitehttps://www.hisoar.com

Leadership

  • Mr. Guorui XuGM & Director · b. 1977
  • Mr. Bing YaoVP, CFO, Board Secretary & Director · b. 1982
  • Mr. Guangshun ChenVP & Non Independent Director · b. 1973
  • Haiyan ZhouAccounting Supervisor
  • Qing Hua PanVice President

Financials

Income Statement

Currency: CNY2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue373.75M506.10M690.76M770.21M1.03B1.06B893.37M1.07B1.30B1.15B1.16B1.32B2.46B2.43B2.31B2.72B2.94B2.47B2.48B2.70B2.17B1.94B1.86B
Growth (%)-+35.41%+36.49%+11.50%+34.36%+2.72%-15.96%+20.29%+20.83%-11.79%+1.34%+13.65%+86.83%-1.24%-5.13%+17.74%+8.20%-15.98%+0.54%+8.83%-19.68%-10.75%-4.01%
Cost of Revenue306.68M412.07M552.74M633.25M894.59M924.26M726.20M791.94M986.60M922.55M959.79M924.27M1.36B1.42B1.34B1.54B1.53B1.43B1.60B2.02B1.98B1.59B1.41B
Gross Profit67.07M94.03M138.02M136.96M140.30M138.73M167.17M282.65M311.84M222.82M200.90M394.86M1.10B1.01B964.82M1.18B1.41B1.04B882.35M680.20M189.17M343.72M454.76M
Gross Margin17.94%18.58%19.98%17.78%13.56%13.05%18.71%26.30%24.02%19.45%17.31%29.93%44.69%41.53%41.79%43.32%48.09%42.22%35.51%25.15%8.71%17.73%24.44%
Operating Expense34.40M33.48M60.69M62.90M92.56M84.65M133.14M167.68M173.55M182.44M303.62M333.52M488.19M682.47M565.15M466.91M495.56M648.03M760.31M570.81M653.42M679.87M466.04M
Operating Income32.66M60.55M77.33M74.06M47.73M54.09M34.04M114.97M138.28M40.38M-102.71M61.34M613.17M328.43M399.67M710.85M918.82M395.27M122.04M109.40M-464.24M-336.14M-11.28M
Operating Margin8.74%11.96%11.19%9.62%4.61%5.09%3.81%10.70%10.65%3.53%-8.85%4.65%24.88%13.49%17.31%26.15%31.24%15.99%4.91%4.05%-21.38%-17.34%-0.61%
EBITDA46.12M74.18M101.91M112.57M97.66M91.92M98.26M160.67M195.00M101.08M63.77M240.57M780.50M666.16M681.90M855.71M1.07B678.62M406.32M429.78M92.70M206.48M284.31M
EBITDA Margin12.34%14.66%14.75%14.62%9.44%8.65%11.00%14.95%15.02%8.82%5.49%18.24%31.67%27.37%29.53%31.48%36.51%27.46%16.35%15.89%4.27%10.65%15.28%
Net Income22.42M35.13M49.60M50.94M31.05M25.60M30.30M85.63M105.06M22.78M-82.11M53.52M516.59M225.02M342.22M605.00M770.78M319.72M95.23M88.01M-420.06M-330.27M-91.08M
Net Income Margin6.00%6.94%7.18%6.61%3.00%2.41%3.39%7.97%8.09%1.99%-7.07%4.06%20.96%9.25%14.82%22.25%26.20%12.94%3.83%3.25%-19.34%-17.04%-4.89%
R&D-------43.81M46.92M42.93M53.89M83.29M117.32M111.38M113.96M111.30M122.55M131.98M164.64M144.91M115.56M132.61M116.93M
R&D as % of Total Revenue-------4.08%3.61%3.75%4.64%6.31%4.76%4.58%4.94%4.09%4.17%5.34%6.63%5.36%5.32%6.84%6.28%
Interest Expense6.46M10.92M11.56M16.35M15.42M22.21M14.78M10.55M13.88M29.31M44.21M61.12M21.32M53.57M57.29M43.69M16.67M12.27M22.92M38.94M39.62M30.81M27.25M
Interest Expense % of Total Revenue1.73%2.16%1.67%2.12%1.49%2.09%1.65%0.98%1.07%2.56%3.81%4.63%0.87%2.20%2.48%1.61%0.57%0.50%0.92%1.44%1.82%1.59%1.46%

Balance Sheet

Currency: CNY2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets362.38M387.38M576.72M921.93M949.75M1.01B996.27M1.14B1.44B1.92B2.11B4.17B4.83B6.91B7.47B7.04B6.75B7.18B8.02B8.39B7.52B7.46B7.33B
Total Liabilities277.36M255.35M393.76M402.66M411.69M465.58M434.48M502.28M698.17M1.18B1.48B988.73M1.26B2.14B2.32B1.64B1.02B1.33B1.91B2.29B1.92B2.32B2.30B
Total Equity81.92M128.76M181.05M516.69M535.08M544.62M558.88M634.89M728.83M711.72M623.11M3.18B3.59B4.77B5.14B5.39B5.72B5.85B6.12B6.11B5.61B5.14B5.04B
Cash41.51M54.93M63.71M302.21M181.97M131.67M123.42M129.10M157.66M194.60M167.94M362.22M727.92M2.82B2.98B1.96B1.56B1.97B1.83B1.49B1.42B1.52B1.38B
Total Debt170.55M186.36M233.10M251.36M231.46M255.81M240.31M235.12M415.03M731.00M973.95M374.98M612.60M952.00M1.34B643.07M200.27M430.44M592.23M1.00B1.04B1.23B-
Net Debt129.04M131.42M169.39M-50.86M49.49M124.15M116.89M106.02M257.36M536.40M806.01M12.76M-115.33M-1.87B-1.63B-1.31B-1.36B-1.54B-1.24B-490.36M-367.05M-288.51M-

Cash Flow

Currency: CNY2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-5.45M42.36M36.07M61.88M51.14M30.61M98.38M180.88M92.62M180.73M60.85M191.56M462.16M629.42M102.68M791.45M612.40M533.87M102.36M116.09M240.54M174.83M-59.68M
Investing Cash Flow-46.53M-33.79M-75.03M-102.12M-111.05M-89.61M-52.67M-145.36M-213.89M-396.90M-239.66M-10.35M-290.85M-216.71M27.54M-1.10B736.60M-70.58M-509.01M-620.32M-128.21M-527.39M-
Financing Cash Flow54.28M4.85M35.23M280.42M-50.45M-27.55M-24.49M-31.81M145.92M207.14M178.12M-2.82M237.75M1.62B-528.98M-906.28M-902.34M-11.19M80.79M-121.88M99.07M3.46M-
Capital Expenditure43.94M42.54M73.74M102.59M112.61M90.40M53.60M146.51M217.52M426.79M281.79M169.06M296.36M124.31M148.99M255.78M160.64M74.18M229.56M179.42M153.08M122.11M74.46M
Free Cash Flow-49.39M-180.15K-37.67M-40.70M-61.47M-59.80M44.78M34.37M-124.91M-246.06M-220.94M22.50M165.81M505.10M-46.32M535.67M451.76M459.69M-127.20M-63.33M87.46M52.73M-134.14M
Dividends Paid6.87M10.96M11.51M27.55M28.52M31.91M28.98M26.62M49.30M79.13M51.38M53.83M170.21M199.26M104.17M204.57M466.68M466.71M32.37M161.87M118.94M28.06M26.29M
FCF to OCF905.44%-0.43%-104.42%-65.77%-120.19%-195.37%45.52%19.00%-134.86%-136.15%-363.08%11.75%35.88%80.25%-45.11%67.68%73.77%86.10%-124.27%-54.55%36.36%30.16%224.77%
Dividend Paid to FCF-13.91%-6082.54%-30.56%-67.68%-46.39%-53.36%64.72%77.44%-39.47%-32.16%-23.26%239.23%102.66%39.45%-224.90%38.19%103.30%101.53%-25.45%-255.60%135.99%53.22%-19.60%

Earnings

Report DateJun 30, 2014Oct 28, 2014Feb 25, 2015Apr 28, 2015Aug 26, 2015Oct 31, 2015Jan 21, 2016Apr 19, 2016Jul 25, 2016Oct 27, 2016Mar 1, 2017Apr 20, 2017Aug 28, 2017Oct 25, 2017Dec 31, 2017Apr 3, 2018Aug 29, 2018Oct 16, 2018Feb 17, 2019Apr 22, 2019Aug 20, 2019Oct 27, 2019Jan 22, 2020Apr 29, 2020Aug 26, 2020Oct 26, 2020Dec 31, 2020Apr 28, 2021Sep 1, 2021Oct 27, 2021Dec 31, 2021Apr 26, 2022Sep 1, 2022Oct 31, 2022Dec 31, 2022Apr 24, 2023Aug 29, 2023Oct 30, 2023Dec 31, 2023Apr 28, 2024Aug 30, 2024Sep 30, 2024Dec 31, 2024Apr 28, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------------------------------------------
EPS Actual0.010.000.060.110.110.080.040.090.110.08-0.130.070.080.030.030.030.140.130.080.130.190.120.050.070.100.06-0.030.040.000.010.010.050.050.02-0.070.03-0.01-0.04-0.240.020.00-0.02-0.220.010.00-0.00-0.060.02-0.06
Surprise-------------------------------------------------
Timing-Pre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hours-Pre-marketPre-marketAfter-hours-After-hoursPre-marketAfter-hours-Pre-marketPre-marketAfter-hours-Pre-marketPre-market--Pre-market-----

Key Statistics & Ratios

Market Cap9.96B
Enterprise Value9.82B
Trailing P/E0.00
Forward P/E86.96
Price / Sales5.08
Price / Book2.01
EPS-0.11
Book Value3.09
Revenue (TTM)1.96B
Gross Profit (TTM)303.42M
EBITDA142.85M
Profit Margin-8.64%
Operating Margin-17.51%
Return on Equity-3.44%
Return on Assets-1.61%
Shares Outstanding1.62B
Shares Float880.35M
Beta0.32
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20231×
0.05May 24, 2023
20221×
0.10May 25, 2022
20211×
0.02Jun 11, 2021
20201×
0.30Feb 21, 2020
20191×
0.30Apr 10, 2019
20181×
0.10May 9, 2018
20171×
0.03Jun 2, 2017
20161×
0.10Mar 1, 2016
20151×
0.10May 20, 2015
20121×
0.07May 22, 2012
20111×
0.05Apr 11, 2011
20101×
0.03May 5, 2010
20091×
0.03May 27, 2009
20081×
0.03Jun 4, 2008
20071×
0.03May 29, 2007

Stock Splits

  • Mar 1, 201620:10
  • May 22, 201220:10
  • May 29, 20071.5:1